Mark Peggie

7.4k citations
56 papers · 5.9k indexed · 1 hit paper · h-index 42
  • Immunology top 2%
    • interferon and immune responses 11
    • Immune Response and Inflammation 8
    • NF-κB Signaling Pathways 12
    • Ubiquitin and proteasome pathways 12
    • Metabolism, Diabetes, and Cancer 8
    • RNA Research and Splicing 7
    • Protein Kinase Regulation and GTPase Signaling 6
  • Aging top 5%
    • Autophagy in Disease and Therapy 6

Mark Peggie

56 papers receiving 5.8k citations

Hit Papers

The Ancient Drug Salicylate Directly Activates AMP-Activa...5902012202620162021100200300400500

Peers

Mark Peggie
Comparison fields: 5 of 123
  • Immunology 1.4k
  • Cancer Research 947
  • Molecular Biology 4.0k
  • Cell Biology 689
  • Aging 59
Replace Natalia Shpiro with:
Natalia Shpiro United Kingdom
Jeffrey P. MacKeigan United States
George P. Livi United States
Nicholas Joza France
Rachel Toth United Kingdom
Steven Xanthoudakis United States
Greg M. Brothers Canada
Claudio Brancolini Italy
Kei Tobiume Japan
Diane C. Fingar United States
Mark Peggie relative to Natalia Shpiro United Kingdom Natalia Shpiro's profile →
Citations per field
00.5×1.5×1.8×
Natalia Shpiro · 1×
Citations per year

Countries citing papers authored by Mark Peggie

Since Specialization
Citations

This map shows the geographic impact of Mark Peggie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Peggie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Peggie more than expected).

Fields of papers citing papers by Mark Peggie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Peggie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Peggie. The network helps show where Mark Peggie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Peggie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Peggie Line = papers co-authored together Mark Peggie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201834
2 201788
3 201686
4 2015135
5 201561
6 2015199
7 201324
8
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinasebreakdown →
2012590
9 201235
10 201213
11 201218
12 2010154
13 2009300
14 200888
15 20086
16 2008137
17 200636
18 2005189
19 200574
20 199121

About Mark Peggie

Mark Peggie is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 56 papers that have together received 5.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (12 papers), NF-κB Signaling Pathways (12 papers), interferon and immune responses (11 papers), Metabolism, Diabetes, and Cancer (8 papers), Immune Response and Inflammation (8 papers), RNA Research and Splicing (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Autophagy in Disease and Therapy (6 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (947 citations) and Molecular Biology (4.0k citations). Mark Peggie has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Philip Cohen, Mark Windheim, Kristopher Clark, Kei Sakamoto, J. Simon C. Arthur, Nick Morrice, Nicholas A. Morrice, Dario R. Alessi, C. James Hastie and Chrisostomos Prodromou. Their work appears in journals such as Biochemical Journal, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, The EMBO Journal and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026